We found that hydroxyurea and aphidicolin induced more potent inhibitory effects on the growth of breast cancer cells expressing UBE2T shRNA than on the growth of cells expressing NS shRNA, and these effects increased in a concentration-dependent manner (Figure 6G). The gene discussed is UBE2T; the disease is breast carcinoma.